Chongqing Huang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Chongqing Huang has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
Guanfeng Yu
Department of Vascular Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China
3 shared publications- Jingyong Huang
Department of Vascular Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China
3 shared publications Anthony Lemaire
Rutgers Robert Wood Johnson Med Sch, Div Cardiothorac Surg, Dept Surg, New Brunswick, NJ USA
1 shared publicationG-F Yu
Wenzhou Med Univ, Affiliated Hosp 1, Dept Vasc Surg, Wenzhou, Peoples R China
1 shared publicationJingyong Huang
Wenzhou Med Univ, Dept Vasc Surg, Affiliated Hosp 1, Wenzhou, Peoples R China
1 shared publicationKangkang Lu
Department of Breast and Thyroid Surgery, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China
1 shared publication
Latest Publications
- Open Access
- 26 August 2022
- Published by AME Publishing Company in Annals of Translational Medicine
- Vol. 10 (16) , 887
Cyclin-dependent kinase 5 contributes to apoptosis of vascular endothelial cells during aortic dissection
Original Article Cyclin-dependent kinase 5 contributes to apoptosis of vascular endothelial cells during aortic dissection Jingyong Huang, Anthony Lemaire, Chongqing Huang
- 26 August 2022
- Published by AME Publishing Company in Annals of Translational Medicine
- Vol. 10 (16) , 887
Open AccessCyclin-dependent kinase 5 contributes to apoptosis of vascular endothelial cells during aortic dissection
Original Article Cyclin-dependent kinase 5 contributes to apoptosis of vascular endothelial cells during aortic dissection Jingyong Huang, Anthony Lemaire, Chongqing Huang
- Open Access
- 1 January 2021
- Published by SAGE Publications in Clinical and Applied Thrombosis/Hemostasis
- Vol. 27
Timing of Endovascular Interventions for Iliac Vein Compression Syndrome With Thrombus
The aim of this study is to explore the timing and method of endovascular intervention for iliac vein compression syndrome (IVCS) with thrombus. Data from 111 patients with IVCS, complicated acute deep vein thrombosis (DVT), or post-thrombotic syndrome (PTS) who underwent endovascular interventions were analyzed retrospectively. Patients were divided into Group A (DVT group), including 56 patients with IVCS and iliofemoral DVT, with or without femoropopliteal DVT, with sudden lower limb swelling, and Group B (PTS group) included 55 patients with IVCS and PTS, including 18 with lower extremity wet ulcers and 32 with lower limb infections. Interventional therapies were used to treat the thrombus and eliminate stenosis and occlusion of the iliac vein. In both groups, clinical symptoms in the lower limbs after surgery were reduced significantly, and PTS incidence was low during long-term follow-up. The cumulative patency rate was 75.2% in the DVT group and 88.6% in the PTS group. Comprehensive interventional therapies are safe and effective in patients with IVCS and thrombi. Long-term efficacy in the PTS group tended to be better than that in the DVT group.
- 1 January 2021
- Published by SAGE Publications in Clinical and Applied Thrombosis/Hemostasis
- Vol. 27
Open AccessTiming of Endovascular Interventions for Iliac Vein Compression Syndrome With Thrombus
The aim of this study is to explore the timing and method of endovascular intervention for iliac vein compression syndrome (IVCS) with thrombus. Data from 111 patients with IVCS, complicated acute deep vein thrombosis (DVT), or post-thrombotic syndrome (PTS) who underwent endovascular interventions were analyzed retrospectively. Patients were divided into Group A (DVT group), including 56 patients with IVCS and iliofemoral DVT, with or without femoropopliteal DVT, with sudden lower limb swelling, and Group B (PTS group) included 55 patients with IVCS and PTS, including 18 with lower extremity wet ulcers and 32 with lower limb infections. Interventional therapies were used to treat the thrombus and eliminate stenosis and occlusion of the iliac vein. In both groups, clinical symptoms in the lower limbs after surgery were reduced significantly, and PTS incidence was low during long-term follow-up. The cumulative patency rate was 75.2% in the DVT group and 88.6% in the PTS group. Comprehensive interventional therapies are safe and effective in patients with IVCS and thrombi. Long-term efficacy in the PTS group tended to be better than that in the DVT group.
- 1 January 2020
- Vol. 24 (12) , 7033-7038
Correlation between carotid atherosclerotic plaque properties and serum levels of IncRNA CCAT2 and miRNA-21613
OBJECTIVE: The purpose of this study was to uncover the clinical values of serum long non-coding RNA (IncRNA) CCAT2 and miRNA-216b in the properties of carotid atherosclerotic plaques. PATIENTS AND METHODS: Patients with carotid atherosclerotic plaques were assigned into stable plaque group (n=60) and unstable plaque (n=75) group based on their examination results of cervical contrast-enhanced CT examination. Maximal plaque thickness (MAPT) and intima-media thickness (IMT) in each group were determined. Serum levels of IncRNA CCAT2 and miRNA-216b in patients with carotid atherosclerotic plaques were detected by Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR). Moreover, the correlation between serum levels of CCAT2 and miRNA-216b was analyzed by Pearson's correlation analysis. Besides, potential correlations of serum levels of CCAT2 and miRNA-216b with MAPT and IMT in patients with carotid atherosclerotic plaques were assessed as well. RESULTS: Results revealed that MAPT and IMT were markedly higher in unstable plaque group than those in stable plaque group. Serum level of CCAT2 was higher in unstable plaque group, while miRNA-216b was lower than those in stable group. A negative correlation was identified between serum levels of CCAT2 and miRNA-216b. In addition, CCAT2 level was positively correlated with IMT and MAPT in patients with carotid atherosclerotic plaques, while miRNA-216b level was negatively correlated with them. CONCLUSIONS: Detection of serum levels of CCAT2 and miRNA-216b could be applied for predicting the rupture of carotid atherosclerotic plaques. They may be potential biomarkers predicting ischemic stroke.
- 1 January 2020
- Vol. 24 (12) , 7033-7038
Correlation between carotid atherosclerotic plaque properties and serum levels of IncRNA CCAT2 and miRNA-21613
OBJECTIVE: The purpose of this study was to uncover the clinical values of serum long non-coding RNA (IncRNA) CCAT2 and miRNA-216b in the properties of carotid atherosclerotic plaques. PATIENTS AND METHODS: Patients with carotid atherosclerotic plaques were assigned into stable plaque group (n=60) and unstable plaque (n=75) group based on their examination results of cervical contrast-enhanced CT examination. Maximal plaque thickness (MAPT) and intima-media thickness (IMT) in each group were determined. Serum levels of IncRNA CCAT2 and miRNA-216b in patients with carotid atherosclerotic plaques were detected by Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR). Moreover, the correlation between serum levels of CCAT2 and miRNA-216b was analyzed by Pearson's correlation analysis. Besides, potential correlations of serum levels of CCAT2 and miRNA-216b with MAPT and IMT in patients with carotid atherosclerotic plaques were assessed as well. RESULTS: Results revealed that MAPT and IMT were markedly higher in unstable plaque group than those in stable plaque group. Serum level of CCAT2 was higher in unstable plaque group, while miRNA-216b was lower than those in stable group. A negative correlation was identified between serum levels of CCAT2 and miRNA-216b. In addition, CCAT2 level was positively correlated with IMT and MAPT in patients with carotid atherosclerotic plaques, while miRNA-216b level was negatively correlated with them. CONCLUSIONS: Detection of serum levels of CCAT2 and miRNA-216b could be applied for predicting the rupture of carotid atherosclerotic plaques. They may be potential biomarkers predicting ischemic stroke.
- 9 February 2018
- Published by Elsevier in Annals of Vascular Surgery
- Vol. 49, 57-63
Midterm Results of Endovascular Treatment for Iliac Vein Compression Syndrome from a Single Center
- 9 February 2018
- Published by Elsevier in Annals of Vascular Surgery
- Vol. 49, 57-63
Midterm Results of Endovascular Treatment for Iliac Vein Compression Syndrome from a Single Center